Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199224-03-2014
24-03-2014
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Naresh B Wadhwa has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199224-03-2014
Financial Results & Limited Review for Dec 31, 2013
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.03-02-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199201-11-2013
Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2013, appointed Mr. Naresh Balwant Wadhwa as an additional Director of the Company. Mr. Wadhwa will be an independent non-executive director.31-10-2013
Financial Results & Limited Review for Sept 30, 2013
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013.31-10-2013
Updates on Outcome of AGM
Marksans Pharma Ltd has submitted to BSE a copy of minutes of the 21st Annual General Meeting (AGM) of the Company was held on September 26, 2013.01-10-2013
Disclosure of Voting results of AGM (Clause 35A)
Marksans Pharma Ltd has submitted to BSE a copy of the disclosures pertaining to the voting results of the 21st Annual General Meeting of the Company held on September 26, 2013 (in terms of Clause 35A of the Listing Agreement).30-09-2013
Outcome of AGM
Marksans Pharma Ltd has informed BSE that Mr. Seetharama Raju Buddharaju who was appointed a Director of the Company in the casual vacancy caused by the resignation of Mr. M.B. Parikh, has ceased to be a Director as such effective from the date of the 21st Annual General Meeting i.e. September 26, 2013.Further, be informed that the Shareholders have, at the 21st Annual General Meeting held on September 26, 2013, appointed Mr. Seetharama Raju...26-09-2013
Fixes Book Closure for AGM
Marksans Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2013 to September 26, 2013 (both days inclusive) for the purpose of 21st Annual General Meeting (AGM) of the Company to be held on September 26, 2013.05-09-2013